Sutro Biopharma, Inc. (STRO) Total Assets by Year
Sutro Biopharma, Inc. closed fiscal year 2025 with $173.8M in total assets, $306.3M in total liabilities and -$132.5M in shareholder equity. This represents a decrease of 55.1% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Sutro Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
STRO Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $173.8M-55.1% | $387.2M-17.7% | $470.7M+15.7% | $406.9M+19.2% | $341.4M-13.4% | $394.1M+152.0% | $156.4M-29.9% | $223.1M+447.3% | $40.8M | N/A |
| Total Liabilities | $306.3M-10.6% | $342.6M+6.7% | $321.1M+69.1% | $189.9M+113.7% | $88.8M+43.2% | $62.1M+5.9% | $58.6M-36.0% | $91.6M-38.8% | $149.8M | N/A |
| Total Equity | -$132.5M-397.0% | $44.6M-70.2% | $149.6M-31.1% | $217.0M-14.1% | $252.6M-23.9% | $332.0M+239.6% | $97.8M-25.7% | $131.5M+220.7% | -$109.0M-19.9% | -$90.9M |
STRO Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $194.5M-25.9% | $242.0M-24.7% | $173.8M-55.1% | $209.7M-53.6% | $262.4M-46.4% | $321.4M-20.3% | $387.2M-17.7% | $451.8M+4.7% | $489.0M+5.2% | $403.4M+12.7% | $470.7M+15.7% | $431.7M+7.7% |
| Total Liabilities | $297.8M+1.1% | $308.9M-11.0% | $306.3M-10.6% | $296.9M-12.8% | $294.5M-12.6% | $347.2M+13.7% | $342.6M+6.7% | $340.6M+6.6% | $336.9M+8.6% | $305.4M+76.9% | $321.1M+69.1% | $319.4M+86.8% |
| Total Equity | -$103.3M-221.7% | -$66.9M-159.1% | -$132.5M-397.0% | -$87.3M-178.5% | -$32.1M-121.1% | -$25.8M-126.3% | $44.6M-70.2% | $111.2M-1.1% | $152.2M-1.6% | $98.0M-47.1% | $149.6M-31.1% | $112.4M-51.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Sutro Biopharma, Inc. financials
Frequently Asked Questions
What was Sutro Biopharma, Inc.'s total assets in fiscal year 2025?
Sutro Biopharma, Inc. closed fiscal year 2025 with $173.8M in total assets, $306.3M in total liabilities and -$132.5M in shareholder equity.
How fast is Sutro Biopharma, Inc.'s total assets growing?
Sutro Biopharma, Inc. (STRO) total assets fell by 55.1% year over year, from $387.2M to $173.8M in fiscal year 2025.
What was Sutro Biopharma, Inc.'s total assets in the most recent quarter?
Sutro Biopharma, Inc. (STRO) reported $194.5M in total assets in Q2 2026. This represents a decrease of 25.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Sutro Biopharma, Inc. (STRO) reported on that line in every period on record.